Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GMAB | Copenhagen | DKK | Real-time | |
GMABc | BATS Europe | DKK | Delayed | |
GMAB | NASDAQ | USD | Real-time | |
0MGB | London | DKK | Real-time | |
GMAB | Vienna | EUR | Real-time |
Today, European shares experienced an upturn, with the STOXX 600 closing 0.3% higher, following a week of declines. This rebound was largely driven by robust earnings reports and...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Three Outside Up | 5H | Current | |||
Mat Hold Bullish | 1D | Current | |||
Doji Star Bearish | 1M | Current | |||
Completed Patterns | |||||
Falling Three Methods | 1W | 1 | Sep 20, 2020 | ||
Bullish Engulfing | 5H | 1 | Oct 02, 2020 08:00 | ||
Three Inside Up | 1W | 2 | Sep 13, 2020 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
Copenhagen | 2,084.0 | 0.0 | 0.0 | 88,114 | -1.98% | DKK | |||
BATS Europe | 2,017.50 | 0.00 | 0.00 | 0 | 0.00% | DKK | |||
NASDAQ | 29.91 | 0.00 | 0.00 | 361,389 | -2.35% | USD | |||
London | 2,079.00 | 2,022.00 | 2,125.00 | 0 | 0.00% | DKK | |||
Vienna | 266.00 | 262.80 | 266.00 | 0 | +0.00% | EUR |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
IAG | 176.75 | 177.70 | 170.95 | +5.25 | +3.06% | 34.56M | 28/03 | ||
Rolls-Royce Holdings | 426.70 | 430.50 | 411.40 | +4.70 | +1.11% | 16.81M | 28/03 | ||
Lloyds Banking | 51.76 | 52.54 | 51.57 | +0.09 | +0.17% | 157.24M | 28/03 | ||
Barclays | 183.20 | 185.74 | 182.82 | +1.68 | +0.93% | 48.73M | 28/03 | ||
Avacta Group | 49.75 | 50.00 | 48.40 | +0.75 | +1.53% | 3.37M | 28/03 | ||
Vodafone Group PLC | 70.460 | 70.720 | 69.700 | +1.040 | +1.50% | 65.30M | 28/03 | ||
JD Sports Fashion | 134.50 | 136.75 | 114.86 | +18.20 | +15.65% | 61.63M | 28/03 | ||
BP | 495.70 | 498.75 | 493.30 | +2.90 | +0.59% | 35.58M | |||
EasyJet | 570.80 | 572.80 | 556.40 | +13.20 | +2.37% | 4.63M | 28/03 | ||
Greatland Gold | 6.200 | 6.600 | 6.100 | -0.270 | -4.17% | 17.37M | 28/03 |
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review